Hosted on MSN3mon
Drug screening platform identifies compound for reinvigorating exhausted CAR-T cellsMoreover, in both allogeneic and syngeneic tumor models, miltefosine significantly enhanced the tumor-clearing capacity of CAR-T cells and T cells. The drug screening platform can assess FDA ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results